Seoul, Seoul-t'ukpyolsi, South Korea | Fund Name | Location |
| Aspen Finance Investors | - |
| B-Con LP | - |
| Belmore Capital | California, Palo Alto, United States |
| Bravos Capital | California, Los Angeles, United States |
| Credit Suisse Loan Funding | - |
| Getz Brothers | - |
| GSX | Japan, Tokyo |
| H Venture Partners | Cincinnati, Ohio, United States |
| Hangzhou Hanzhen Investment Management | China, Hangzhou, Zhejiang |
| Health Innovations | Netherlands, Utrecht, Utrecht |
| HVF Labs | California, San Francisco, United States |
| Incubio | Barcelona, Catalonia, Spain |
| Interprise Technology Partners | Florida, Miami, United States |
| Kunshan Hi-tech Venture Capital | China, Jiangsu, Suzhou |
| Monta Vista Capital | California, Sunnyvale, United States |
| PHW Group | Germany, Niedersachsen, Visbek |
| Piramal Enterprises | India, Maharashtra, Mumbai |
| Tsingbay Venture Capital | China, Guangdong, Shenzhen |
| Yatou Zhangjiakou Touzi | China, Hebei, Zhangjiakou |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
CURAUM | $9M | 26 Sep 2023 | Daejeon, Taejon-jikhalsi, South Korea | ||
Scone | 25 Aug 2022 | South Korea, Gangwon-do, South Korea | |||
Quriously | $8M | 29 Jul 2022 | Seocho, Seoul-t'ukpyolsi, South Korea | ||
WHYNOT Media | $19M | 21 Jul 2022 | South Korea, Gangwon-do, South Korea | ||
vling | $2M | 04 Jul 2022 | Seongnam, Kyonggi-do, South Korea | ||
SYM Healthcare | $261K | 27 Jun 2022 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
MedLAB | 21 May 2022 | Busan, Pusan-jikhalsi, South Korea | |||
Walk in step | $87K | 16 May 2022 | South Korea, Gangwon-do, South Korea | ||
Um Class | $174K | 13 May 2022 | Busan, Pusan-jikhalsi, South Korea |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
CURAUM | $9M | 26 Sep 2023 | Daejeon, Taejon-jikhalsi, South Korea | ||
Scone | 25 Aug 2022 | South Korea, Gangwon-do, South Korea | |||
Quriously | $8M | 29 Jul 2022 | Seocho, Seoul-t'ukpyolsi, South Korea | ||
WHYNOT Media | $19M | 21 Jul 2022 | South Korea, Gangwon-do, South Korea | ||
vling | $2M | 04 Jul 2022 | Seongnam, Kyonggi-do, South Korea | ||
SYM Healthcare | $261K | 27 Jun 2022 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
MedLAB | 21 May 2022 | Busan, Pusan-jikhalsi, South Korea | |||
Walk in step | $87K | 16 May 2022 | South Korea, Gangwon-do, South Korea | ||
Um Class | $174K | 13 May 2022 | Busan, Pusan-jikhalsi, South Korea |
